Longevity Health (XAGE) Competitors $1.92 -0.40 (-17.24%) As of 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XAGE vs. BTCY, ALUR, NVNO, NXL, IINN, INBS, OSRH, BLAC, MHUA, and SINTShould you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include Biotricity (BTCY), Allurion Technologies (ALUR), enVVeno Medical (NVNO), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), Intelligent Bio Solutions (INBS), OSR (OSRH), Bellevue Life Sciences Acquisition (BLAC), Meihua International Medical Technologies (MHUA), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Longevity Health vs. Its Competitors Biotricity Allurion Technologies enVVeno Medical Nexalin Technology Inspira Technologies OXY B.H.N. Intelligent Bio Solutions OSR Bellevue Life Sciences Acquisition Meihua International Medical Technologies Sintx Technologies Longevity Health (NASDAQ:XAGE) and Biotricity (NASDAQ:BTCY) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation. Is XAGE or BTCY more profitable? Biotricity has a net margin of -80.42% compared to Longevity Health's net margin of -682.67%. Company Net Margins Return on Equity Return on Assets Longevity Health-682.67% N/A -261.90% Biotricity -80.42%N/A -188.47% Which has stronger valuation & earnings, XAGE or BTCY? Longevity Health has higher earnings, but lower revenue than Biotricity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLongevity Health$50K68.35-$10.37MN/AN/ABiotricity$12.06M1.50-$14.09M-$0.21-3.45 Which has more risk and volatility, XAGE or BTCY? Longevity Health has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Do analysts recommend XAGE or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of XAGE or BTCY? 24.2% of Longevity Health shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 29.0% of Longevity Health shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to XAGE or BTCY? In the previous week, Biotricity had 2 more articles in the media than Longevity Health. MarketBeat recorded 3 mentions for Biotricity and 1 mentions for Longevity Health. Longevity Health's average media sentiment score of 1.89 beat Biotricity's score of 0.21 indicating that Longevity Health is being referred to more favorably in the media. Company Overall Sentiment Longevity Health Very Positive Biotricity Neutral SummaryBiotricity beats Longevity Health on 6 of the 11 factors compared between the two stocks. Get Longevity Health News Delivered to You Automatically Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAGE vs. The Competition Export to ExcelMetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.13M$206.96M$2.55B$10.15BDividend YieldN/AN/A2.51%4.61%P/E RatioN/A2.0826.5325.92Price / Sales68.355.3285.2983.33Price / CashN/A3.9745.6359.91Price / Book-0.281.6134.656.29Net Income-$10.37M-$66.04M$16.40M$270.85M7 Day Performance-20.99%1.53%1.75%3.36%1 Month Performance-13.12%-4.17%4.27%6.41%1 Year PerformanceN/A133.81%34.15%28.26% Longevity Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAGELongevity HealthN/A$1.92-17.2%N/AN/A$4.13M$50K0.0014Positive NewsHigh Trading VolumeBTCYBiotricityN/A$0.69+14.4%N/A+98.3%$17.19M$12.06M-0.6440Gap UpALURAllurion Technologies2.2242 of 5 stars$2.20+3.4%$22.83+936.5%-85.9%$16.50M$32.11M-0.18501Short Interest ↑NVNOenVVeno Medical0.6251 of 5 stars$0.77-2.0%N/A-85.0%$15.18MN/A-0.6430Short Interest ↑Gap UpNXLNexalin Technology2.1478 of 5 stars$0.84-1.6%$5.00+498.0%+5.8%$14.81M$170K-1.103Short Interest ↑Gap UpIINNInspira Technologies OXY B.H.N.1.758 of 5 stars$1.21+7.1%$2.00+65.3%+3.6%$14.26MN/A0.0020News CoverageShort Interest ↑Gap UpINBSIntelligent Bio Solutions0.6751 of 5 stars$1.55+2.0%N/A-15.2%$13.65M$3.05M-0.7610OSRHOSRN/A$0.58-3.0%N/AN/A$12.80MN/A0.00N/ABLACBellevue Life Sciences AcquisitionN/A$0.58-3.0%N/A-94.5%$12.16MN/A0.00N/AHigh Trading VolumeMHUAMeihua International Medical Technologies1.6393 of 5 stars$0.37-3.6%N/A-61.7%$12.08M$96.90M0.00620Positive NewsShort Interest ↓High Trading VolumeSINTSintx Technologies1.9706 of 5 stars$5.51+25.8%$28.00+408.2%+38.0%$12.08M$2.89M-0.1140Gap Up Related Companies and Tools Related Companies Biotricity Alternatives Allurion Technologies Alternatives enVVeno Medical Alternatives Nexalin Technology Alternatives Inspira Technologies OXY B.H.N. Alternatives Intelligent Bio Solutions Alternatives OSR Alternatives Bellevue Life Sciences Acquisition Alternatives Meihua International Medical Technologies Alternatives Sintx Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAGE) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
